Can flecainide totally eliminate bidirectional ventricular tachycardia in pediatric patients with Andersen-Tawil syndrome?

Andersen-Tawil syndrome (ATS) is a disorder that causes episodes of muscle weakness (periodic paralysis), changes in heart rhythm, and developmental abnormalities. QT prolongation and ventricular arrhythmias, including bidirectional ventricular tachycardia (VT) and polymorphic VT, may occur. About 6...

Full description

Bibliographic Details
Main Authors: Yakup Ergül, Senem Özgür, Sertaç Hanedan Onan, Volkan Tuzcu
Format: Article
Language:English
Published: KARE Publishing 2018-11-01
Series:Türk Kardiyoloji Derneği Arşivi
Subjects:
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-77856
_version_ 1797906936019025920
author Yakup Ergül
Senem Özgür
Sertaç Hanedan Onan
Volkan Tuzcu
author_facet Yakup Ergül
Senem Özgür
Sertaç Hanedan Onan
Volkan Tuzcu
author_sort Yakup Ergül
collection DOAJ
description Andersen-Tawil syndrome (ATS) is a disorder that causes episodes of muscle weakness (periodic paralysis), changes in heart rhythm, and developmental abnormalities. QT prolongation and ventricular arrhythmias, including bidirectional ventricular tachycardia (VT) and polymorphic VT, may occur. About 60% of all cases of the disorder are caused by mutations in the KCNJ2 gene. A 13-year-old female patient was referred for frequent premature ventricular contractions. Suspicion of ATS due to dysmorphic findings, electrocardiogram changes, and periodic muscle weakness was genetically confirmed. Beta-blocker therapy was initiated as a first-line treatment for bidirectional VT and frequent polymorphic premature ventricular contractions. Despite proper treatment, the VT attacks were not brought under control. Flecainide was added to the treatment regime. The number of premature ventricular contractions was dramatically reduced with flecainide and the VT attacks completely disappeared. This patient is a rare example of ATS in our country. This article provides a description of successful management of rhythm disturbance in a patient with ATS
first_indexed 2024-04-10T10:28:34Z
format Article
id doaj.art-37ce2ed10896435eaf263d75a6ee68f3
institution Directory Open Access Journal
issn 1016-5169
language English
last_indexed 2024-04-10T10:28:34Z
publishDate 2018-11-01
publisher KARE Publishing
record_format Article
series Türk Kardiyoloji Derneği Arşivi
spelling doaj.art-37ce2ed10896435eaf263d75a6ee68f32023-02-15T16:21:13ZengKARE PublishingTürk Kardiyoloji Derneği Arşivi1016-51692018-11-0146871872210.5543/tkda.2017.77856TKDA-77856Can flecainide totally eliminate bidirectional ventricular tachycardia in pediatric patients with Andersen-Tawil syndrome?Yakup Ergül0Senem Özgür1Sertaç Hanedan Onan2Volkan Tuzcu3Department of Pediatric Cardiology and Arrhythmia, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, TurkeyDepartment of Pediatric Cardiology and Arrhythmia, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, TurkeyDepartment of Pediatric Cardiology, Bağcılar Training and Research Hospital, İstanbul, TurkeyDepartment of Pediatric Cardiology and Arrhythmia, Medipol University Hospital, İstanbul, TurkeyAndersen-Tawil syndrome (ATS) is a disorder that causes episodes of muscle weakness (periodic paralysis), changes in heart rhythm, and developmental abnormalities. QT prolongation and ventricular arrhythmias, including bidirectional ventricular tachycardia (VT) and polymorphic VT, may occur. About 60% of all cases of the disorder are caused by mutations in the KCNJ2 gene. A 13-year-old female patient was referred for frequent premature ventricular contractions. Suspicion of ATS due to dysmorphic findings, electrocardiogram changes, and periodic muscle weakness was genetically confirmed. Beta-blocker therapy was initiated as a first-line treatment for bidirectional VT and frequent polymorphic premature ventricular contractions. Despite proper treatment, the VT attacks were not brought under control. Flecainide was added to the treatment regime. The number of premature ventricular contractions was dramatically reduced with flecainide and the VT attacks completely disappeared. This patient is a rare example of ATS in our country. This article provides a description of successful management of rhythm disturbance in a patient with ATShttps://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-77856bidirectional ventricular tachycardiaflecainide; long qt.
spellingShingle Yakup Ergül
Senem Özgür
Sertaç Hanedan Onan
Volkan Tuzcu
Can flecainide totally eliminate bidirectional ventricular tachycardia in pediatric patients with Andersen-Tawil syndrome?
Türk Kardiyoloji Derneği Arşivi
bidirectional ventricular tachycardia
flecainide; long qt.
title Can flecainide totally eliminate bidirectional ventricular tachycardia in pediatric patients with Andersen-Tawil syndrome?
title_full Can flecainide totally eliminate bidirectional ventricular tachycardia in pediatric patients with Andersen-Tawil syndrome?
title_fullStr Can flecainide totally eliminate bidirectional ventricular tachycardia in pediatric patients with Andersen-Tawil syndrome?
title_full_unstemmed Can flecainide totally eliminate bidirectional ventricular tachycardia in pediatric patients with Andersen-Tawil syndrome?
title_short Can flecainide totally eliminate bidirectional ventricular tachycardia in pediatric patients with Andersen-Tawil syndrome?
title_sort can flecainide totally eliminate bidirectional ventricular tachycardia in pediatric patients with andersen tawil syndrome
topic bidirectional ventricular tachycardia
flecainide; long qt.
url https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-77856
work_keys_str_mv AT yakupergul canflecainidetotallyeliminatebidirectionalventriculartachycardiainpediatricpatientswithandersentawilsyndrome
AT senemozgur canflecainidetotallyeliminatebidirectionalventriculartachycardiainpediatricpatientswithandersentawilsyndrome
AT sertachanedanonan canflecainidetotallyeliminatebidirectionalventriculartachycardiainpediatricpatientswithandersentawilsyndrome
AT volkantuzcu canflecainidetotallyeliminatebidirectionalventriculartachycardiainpediatricpatientswithandersentawilsyndrome